The Breakout Rheum™ en The Breakout Rheum™, a podcast for US healthcare professionals brought to you by AbbVie, delivers expert insights on topics relevant to today’s rheumatology practitioners. Tune in for one-on-one conversations between leading rheumatologists. Visit www.RxAbbVie.com for the Prescribing Information, including BOXED WARNING, for the treatment options mentioned in these podcasts. https://megaphone.imgix.net/podcasts/f39c02d2-9009-11f0-a9ca-e7e92cb6725a/image/749d47d73e32eb7bd09881d4b7d9fb1d.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress The Breakout Rheum™ no episodic AbbVie The Breakout Rheum™, a podcast for US healthcare professionals brought to you by AbbVie, delivers expert insights on topics relevant to today’s rheumatology practitioners. Tune in for one-on-one conversations between leading rheumatologists. Visit www.RxAbbVie.com for the Prescribing Information, including BOXED WARNING, for the treatment options mentioned in these podcasts. The Breakout Rheum™, a podcast for US healthcare professionals brought to you by AbbVie, delivers expert insights on topics relevant to today’s rheumatology practitioners. Tune in for one-on-one conversations between leading rheumatologists.

Visit www.RxAbbVie.com for the Prescribing Information, including BOXED WARNING, for the treatment options mentioned in these podcasts.

]]> AbbVie rheumpodcasts@abbvie.com Expert Discussions: Latest Safety Data for a JAK Inhibitor Dr. Angela Crowley and Dr. Marisa Mizus discuss the evolving landscape of safety data across two rheumatic diseases, including rheumatoid arthritis, and look at how longer-term data can provide additional context for patient conversations and treatment decisions.  Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast.  HOST:  AbbVie  GUEST: Marisa Mizus, MD Wed, 07 Oct 2026 16:47:00 -0000 full AbbVie Dr. Angela Crowley and Dr. Marisa Mizus discuss the evolving landscape of safety data across two rheumatic diseases, including rheumatoid arthritis, and look at how longer-term data can provide additional context for patient conversations and treatment decisions.  Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast.  HOST:  AbbVie  GUEST: Marisa Mizus, MD Dr. Angela Crowley and Dr. Marisa Mizus discuss the evolving landscape of safety data across two rheumatic diseases, including rheumatoid arthritis, and look at how longer-term data can provide additional context for patient conversations and treatment decisions. 

Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast. 


HOST:  AbbVie 

GUEST: Marisa Mizus, MD


]]> 1661 no A Steroid-Sparing Therapy for Giant Cell Arteritis Dr. Brown welcomes guest Dr. Anisha Dua, Rheumatology Fellowship Program Director and Director of the Vasculitis Center at Northwestern University Feinberg School of Medicine, to discuss the importance of steroid-free remission for patients with giant cell arteritis and to explore Phase 3 clinical trial data on a steroid-sparing therapy for these patients. Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast. Wed, 07 Oct 2026 16:47:00 -0000 full AbbVie Dr. Brown welcomes guest Dr. Anisha Dua, Rheumatology Fellowship Program Director and Director of the Vasculitis Center at Northwestern University Feinberg School of Medicine, to discuss the importance of steroid-free remission for patients with giant cell arteritis and to explore Phase 3 clinical trial data on a steroid-sparing therapy for these patients. Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast. Dr. Brown welcomes guest Dr. Anisha Dua, Rheumatology Fellowship Program Director and Director of the Vasculitis Center at Northwestern University Feinberg School of Medicine, to discuss the importance of steroid-free remission for patients with giant cell arteritis and to explore Phase 3 clinical trial data on a steroid-sparing therapy for these patients.

Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast.

]]> 2334 no Managing Giant Cell Arteritis Long-Term Dr. Angela Crowley, Chicago chapter leader for the Association of Women in Rheumatology and principal investigator on several clinical trials, hosts a conversation with Dr. Brian Jaros, Assistant Professor of Medicine in the Division of Rheumatology at Northwestern University, to discuss the long-term data now available for a steroid-sparing therapy for giant cell arteritis.  Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast.  HOST: AbbVie GUEST:  Brian Jaros, MD Wed, 07 Oct 2026 16:47:00 -0000 full AbbVie Dr. Angela Crowley, Chicago chapter leader for the Association of Women in Rheumatology and principal investigator on several clinical trials, hosts a conversation with Dr. Brian Jaros, Assistant Professor of Medicine in the Division of Rheumatology at Northwestern University, to discuss the long-term data now available for a steroid-sparing therapy for giant cell arteritis.  Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast.  HOST: AbbVie GUEST:  Brian Jaros, MD Dr. Angela Crowley, Chicago chapter leader for the Association of Women in Rheumatology and principal investigator on several clinical trials, hosts a conversation with Dr. Brian Jaros, Assistant Professor of Medicine in the Division of Rheumatology at Northwestern University, to discuss the long-term data now available for a steroid-sparing therapy for giant cell arteritis. 

Click here for Prescribing Information, including BOXED WARNING, for the treatment option mentioned in this podcast. 


HOST: AbbVie

GUEST:  Brian Jaros, MD


]]> 2027 no Supporting Treatment Goals in Bio-Naïve PsA Patients In this episode, host Brittany Panico, DO, a board-certified rheumatologist and Chief of Rheumatology at Summit Rheumatology in Gilbert, Arizona, is joined by Saakshi Khattri, MD. Dr. Khattri is a triple board-certified internist, rheumatologist, and dermatologist and Director of the Center for Connective Tissue Diseases at the Icahn School of Medicine at Mount Sinai in New York. Together, Drs. Panico and Khattri explore treatment strategies for patients with psoriatic arthritis. From initiating therapy in bio-naïve patients to supporting treatment goals, hear the discussion on tackling this multidomain disease and discover the outcomes that matter most to patients. Click here for Prescribing Information for the treatment option mentioned in this podcast. Please see below for important information on the support programs mentioned in this episode: • Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals. • With the Savings Card for the treatment option mentioned in this podcast, eligible commercially insured patients may pay as little as $0 per dose. Terms and Conditions of the copay assistance program apply. For full Terms and Conditions, visit the website here or call 1-866-759-7494 for more information. HOST: AbbVie GUEST: Saakshi Khattri, MD Thu, 02 Jul 2026 16:56:00 -0000 full AbbVie In this episode, host Brittany Panico, DO, a board-certified rheumatologist and Chief of Rheumatology at Summit Rheumatology in Gilbert, Arizona, is joined by Saakshi Khattri, MD. Dr. Khattri is a triple board-certified internist, rheumatologist, and dermatologist and Director of the Center for Connective Tissue Diseases at the Icahn School of Medicine at Mount Sinai in New York. Together, Drs. Panico and Khattri explore treatment strategies for patients with psoriatic arthritis. From initiating therapy in bio-naïve patients to supporting treatment goals, hear the discussion on tackling this multidomain disease and discover the outcomes that matter most to patients. Click here for Prescribing Information for the treatment option mentioned in this podcast. Please see below for important information on the support programs mentioned in this episode: • Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals. • With the Savings Card for the treatment option mentioned in this podcast, eligible commercially insured patients may pay as little as $0 per dose. Terms and Conditions of the copay assistance program apply. For full Terms and Conditions, visit the website here or call 1-866-759-7494 for more information. HOST: AbbVie GUEST: Saakshi Khattri, MD In this episode, host Brittany Panico, DO, a board-certified rheumatologist and Chief of Rheumatology at Summit Rheumatology in Gilbert, Arizona, is joined by Saakshi Khattri, MD. Dr. Khattri is a triple board-certified internist, rheumatologist, and dermatologist and Director of the Center for Connective Tissue Diseases at the Icahn School of Medicine at Mount Sinai in New York. Together, Drs. Panico and Khattri explore treatment strategies for patients with psoriatic arthritis. From initiating therapy in bio-naïve patients to supporting treatment goals, hear the discussion on tackling this multidomain disease and discover the outcomes that matter most to patients.

Click here for Prescribing Information for the treatment option mentioned in this podcast.

Please see below for important information on the support programs mentioned in this episode:

• Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing healthcare professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

• With the Savings Card for the treatment option mentioned in this podcast, eligible commercially insured patients may pay as little as $0 per dose. Terms and Conditions of the copay assistance program apply. For full Terms and Conditions, visit the website here or call 1-866-759-7494 for more information.


HOST: AbbVie

GUEST: Saakshi Khattri, MD

]]> 1477 no